Bausch Health Cos Comprehensive Income 2010-2024 | BHC

Bausch Health Cos comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Bausch Health Cos Annual Comprehensive Income
(Millions of US $)
2023 $-1,881
2022 $-2,056
2021 $-1,924
2020 $-2,133
2019 $-2,086
2018 $-2,137
2017 $-1,896
2016 $-2,108
2015 $-1,542
2014 $-916
2013 $-133
2012 $-119
2011 $-280
2010 $99
2009 $44
Bausch Health Cos Quarterly Comprehensive Income
(Millions of US $)
2024-06-30 $-2,007
2024-03-31 $-1,917
2023-12-31 $-1,881
2023-09-30 $-2,051
2023-06-30 $-1,902
2023-03-31 $-1,989
2022-12-31 $-2,056
2022-09-30 $-2,265
2022-06-30 $-2,002
2022-03-31 $-1,974
2021-12-31 $-1,924
2021-09-30 $-1,923
2021-06-30 $-2,182
2021-03-31 $-2,256
2020-12-31 $-2,133
2020-09-30 $-2,207
2020-06-30 $-2,223
2020-03-31 $-2,281
2019-12-31 $-2,086
2019-09-30 $-2,156
2019-06-30 $-2,061
2019-03-31 $-2,116
2018-12-31 $-2,137
2018-09-30 $-2,053
2018-06-30 $-2,068
2018-03-31 $-1,852
2017-12-31 $-1,896
2017-09-30 $-1,888
2017-06-30 $-1,965
2017-03-31 $-2,020
2016-12-31 $-2,108
2016-09-30 $-1,579
2016-06-30 $-1,574
2016-03-31 $-1,479
2015-12-31 $-1,542
2015-09-30 $-1,463
2015-06-30 $-1,292
2015-03-31 $-1,328
2014-12-31 $-916
2014-09-30 $-552
2014-06-30 $-105
2014-03-31 $-140
2013-12-31 $-133
2013-09-30 $-160
2013-06-30 $-344
2013-03-31 $-197
2012-12-31 $-119
2012-09-30 $-120
2012-06-30 $-227
2012-03-31 $-30
2011-12-31 $-280
2011-09-30 $-186
2011-06-30 $283
2011-03-31 $218
2010-12-31 $99
2010-09-30 $47
2010-06-30 $42
2010-03-31 $48
2009-12-31 $44
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.956B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Assembly Biosciences (ASMB) United States $0.117B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00